Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.’s Net Profit Dropped 55.1% in First Three Quarters of 2023

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (北京万泰生物药业股份有限公司) (603392.SH) reported a net profit of 1.8 billion yuan in the first three quarters of 2023, down 55.1% year-on-year.

Meanwhile, the company posted 5 billion yuan in revenue, down 42.6% year-on-year.

At the end of the reporting period, it had 16.5 billion yuan in total assets and 3 billion yuan in total liabilities, with a liability-to-asset ratio of 18%.